Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GSK)
NYSE:GSK
Holding GSK?
Track your performance easily
GSK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$33.68 - $45.93
Previous Close$42.43
Volume6.51M
Average Volume (3M)3.54M
Market Cap
$86.18B
Enterprise Value$102.32B
Total Cash (Recent Filing)£5.18B
Total Debt (Recent Filing)£18.02B
Price to Earnings (P/E)17.0
Beta0.32
Next Earnings
Oct 30, 2024EPS Estimate
$1.22Last Dividend Ex-Date
Aug 16, 2024Dividend Yield3.53%
Share Statistics
EPS (TTM)2.50
Shares Outstanding2,072,530,561
10 Day Avg. Volume3,403,558
30 Day Avg. Volume3,540,312
Standard Deviation0.07
R-Squared0.27
Alpha-0.00175
Financial Highlights & Ratios
Price to Book (P/B)12.23
Price to Sales (P/S)2.12
Price to Cash Flow (P/CF)16.10
P/FCF Ratio25.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$49.50Price Target Upside18.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
GlaxoSmithKline News
Ownership Overview
0.00%
Insiders
4.68% Mutual Funds
9.83% Other Institutional Investors
85.49% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was $33.67 and its highest was $45.92 in the past 12 months.
What is GlaxoSmithKline’s market cap?
Currently, no data Available
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Oct 30, 2024 which is in 40 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on Jul 31, 2024. The company reported $1.115 earnings per share for the quarter, beating the consensus estimate of $0.978 by $0.137.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Quarterly dividend of $0.38 which represents an annual dividend yield of 3.53%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is $1.22.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 2,072,530,500 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of $1.115 in its last earnings report, beating expectations of $0.978. Following the earnings report the stock price went down -2.512%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Among the largest hedge funds holding GlaxoSmithKline’s share is Dodge & Cox. It holds GlaxoSmithKline’s shares valued at 3B.
---
GlaxoSmithKline Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$49.50 (18.93% Upside)
$49.50 (18.93% Upside)
Blogger Sentiment
Bullish
GSK Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 3.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.88%
12-Months-Change
Fundamentals
Return on Equity
29.70%
Trailing 12-Months
Asset Growth
-2.90%
Trailing 12-Months
Company Description
GlaxoSmithKline
Founded in 1715 and headquartered in Brentford, U.K., GlaxoSmithKline Plc is a global healthcare company which develops and manufactures pharmaceutical medicines in therapeutic areas, vaccines and consumer healthcare products in wellness, oral health, nutrition, and skin health categories.
---
GSK Company Deck
---
GSK Earnings Call
Q2 2024
0:00 / 0:00
---
GSK Stock 12 Month Forecast
Average Price Target
$49.50
▲(18.93% Upside)
Technical Analysis
Best Analysts Covering GSK
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+3.23%
reiterated a buy rating 10 days ago
Copying Kerry Holford's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +3.23% per trade.
---